Potential Role of Sirtuin as a Therapeutic Target for Neurodegenerative Diseases

키워드

참고문헌 (33)

1. Muchowski PJ, "Modulation of neurodegeneration by molecular chaperones", Nat Rev Neurosci, 6, pp.11~22 (2005)
2. Guarente L, "Sir2 links chromatin silencing, metabolism, and aging", Genes Dev, 14, pp.1021~1026 (2000)
3. Frye RA, "Characterization of five human cDNAs with homology to the yeast SIR2 gene: Sir2-like proteins (sirtuins) metabolize NAD and may have protein ADP-ribosyltransferase activity", Biochem Biophys Res Commun, 260, pp.273~279 (1999)
4. Oberdoerffer P, "The role of nuclear architecture in genomic instability and ageing", Nat Rev Mol Cell Biol, 8, pp.692~702 (2007)
5. Westphal CH, "A therapeutic role for sirtuins in diseases of aging?", Trends Biochem Sci, 32, pp.555~560 (2007)
6. Yamamoto H, "Sirtuin functions in health and disease", Mol Endocrinol, 21, pp.1745~1755 (2007)
7. Rine J, "Four genes responsible for a position effect on expression from HML and HMR in Saccharomyces cerevisiae", Genetics, 116, pp.9~22 (1987)
8. North BJ, "The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase", Mol Cell, 11, pp.437~444 (2003)
9. Michishita E, "Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins", Mol Biol Cell, 16, pp.4623~4635 (2005)
10. Kennedy BK, "Redistribution of silencing proteins from telomeres to the nucleolus is associated with extension of life span in S. cerevisiae", Cell, 89, pp.381~391 (1997)
11. Gan L, "Paths of convergence: sirtuins in aging and neurodegeneration", Neuron, 58, pp.10~14 (2008)
12. Vaziri H, "hSIR2 (SIRT1) functions as an NAD-dependent p53 deacetylase", Cell, 107통권 : 10, pp.149~159 (2001)
13. Daitoku H, "Silent information regulator 2 potentiates Foxo1-mediated transcription through its deacetylase activity", Proc Natl Acad Sci U S A, 통권 : 101, pp.10042~10047 (2004)
14. Brunet A, "Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase", Science, 303, pp.2011~2015 (2004)
15. Sakamoto J, "Predominant expression of Sir2alpha, an NAD-dependent histone deacetylase, in the embryonic mouse heart and brain", FEBS Lett, 556, pp.281~286 (2004)
16. Cheng HL, "Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice", Proc Natl Acad Sci U S A, 통권 : 100, pp.10794~10799 (2003)
17. Wu A, "Oxidative stress modulates Sir2alpha in rat hippocampus and cerebral cortex", Eur J Neurosci, 23, pp.2573~2580 (2006)
18. Lee IH, "A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy", Proc Natl Acad Sci U S A, 통권 : 105, pp.3374~3379 (2008)
19. Perrod S, "A cytosolic NAD-dependent deacetylase, Hst2p, can modulate nucleolar and telomeric silencing in yeast", EMBO J, 20, pp.197~209 (2001)
20. Outeiro TF, "Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson’s disease", Science, 317, pp.516~519 (2007)
21. Dryden SC, "Role for human SIRT2 NAD-dependent deacetylase activity in control of mitotic exit in the cell cycle", Mol Cell Biol, 23, pp.3173~3185 (2003)
22. Li W, "Sirtuin 2, a mammalian homolog of yeast silent information regulator-2 longevity regulator, is an oligodendroglial protein that decelerates cell differ entiation through deacetylating alpha-tubulin", J Neurosci, 27, pp.2606~2616 (2007)
23. Valerio A, "NF-kappaB pathway: a target for preventing beta-amyloid (Abeta)-induced neuronal damage and Abeta42 production", Eur J Neurosci, 23, pp.1711~1720 (2006)
24. Yeung F, "Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase", EMBO J, 23, pp.2369~2380 (2004)
25. Wang J, "Caloric restriction attenuates beta-amyloid neuropathology in a mouse model of Alzheimer’s disease", FASEB J, 19, pp.659~661 (2005)
26. Patel NV, "Caloric restriction attenuates Abeta-deposition in Alzheimer transgenic models", Neurobiol Aging, 26, pp.995~1000 (2005)
27. Guarente L, "Sirtuins as potential targets for metabolic syndrome", Nature, 444, pp.868~874 (2006)
28. Okawara M, "Resveratrol protects dopaminergic neurons in midbrain slice culture from multiple insults", Biochem Pharmacol, 73, pp.550~560 (2007)
29. Barber SC, "Oxidative stress in ALS: a mechanism of neurodegeneration and a therapeutic target", Biochim Biophys Acta, 1762, pp.1051~1067 (2006)
30. Shibata N, "Effects of the PPARgamma activator pioglitazone on p38 MAP kinase and IkappaBalpha in the spinal cord of a transgenic mouse model of amyotrophic lateral sclerosis", Neuropathology, 28, pp.387~398 (2008)
31. Kiaei M, "Peroxisome Proliferator-Activated Receptor-gamma in Amyotrophic Lateral Sclerosis and Huntington’s Disease", PPAR Res, 2008, pp.418~765 (2008)
32. Kim D, "SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer’s disease and amyotrophic lateral sclerosis", EMBO J, 26, pp.3169~3179 (2007)
33. Baur JA, "Therapeutic potential of resveratrol: the in vivo evidence", Nat Rev Drug Discov, 5, pp.493~506 (2006)

관련 논문AI추천